Metraipolis › archive › dc_8566e686d08a

Post hoc subgroup analysis of neoadjuvant gemcitabine plus S1 vs gemcitabine plus nab paclitaxel in elderly resectable/borderline resectable pancreatic… — Europe PMC PMID:41224817

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41224817
DOI
10.1038/s41598-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-08T15:20:02.435Z
SHA-256 of the archived text
e309f99fbe1212085b3531f6341ff9999cf1e927fb86916e685cdd1557065cdf
Stable URL of this page
https://metraipolis.com/documento/dc_8566e686d08a

How to cite

Post hoc subgroup analysis of neoadjuvant gemcitabine plus S1 vs gemcitabine plus nab paclitaxel in elderly resectable/borderline resectable pancreatic… — Europe PMC PMID:41224817 — Europe PMC (en), https://europepmc.org/article/MED/41224817 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8566e686d08a (Metraipolis archive dc_8566e686d08a, sha256 e309f99fbe1212085b3531f6341ff9999cf1e927fb86916e685cdd1557065cdf)
BibTeX
@misc{dc8566e686d08a,
  title = {Post hoc subgroup analysis of neoadjuvant gemcitabine plus S1 vs gemcitabine plus nab paclitaxel in elderly resectable/borderline resectable pancreatic… — Europe PMC PMID:41224817},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41224817},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8566e686d08a; sha256 e309f99fbe1212085b3531f6341ff9999cf1e927fb86916e685cdd1557065cdf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41224817. Agents can read the archived copy with the MCP tool read_document.